Ionis Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2017
Total Assets: $1.32B
Liabilities Breakdown FY2017
Total Liabilities: $957.5M
Asset Breakdown
Total Assets: $1.32B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $129.6M | 9.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $10.0M | 0.8% |
| Property, Plant & Equipment | $121.9M | 9.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $22.0M | 1.7% |
| Other Assets | $1.04B | 78.6% |
Liabilities Breakdown
Total Liabilities: $957.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $24.9M | 2.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $932.6M | 97.4% |